Volitionrx Return on Equity (ROE) Growth & History (VNRX)
Volitionrx's return on equity was −404.02% for fiscal 2022.
View full Volitionrx company overviewVolitionrx annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −404.02% | −245.33 pp |
| 2021 | 2021-12-31 | −158.69% | −24.89 pp |
| 2020 | 2020-12-31 | −133.80% | −11.55 pp |
| 2019 | 2019-12-31 | −122.24% | +40.74 pp |
| 2018 | 2018-12-31 | −162.99% | −68.11 pp |
| 2017 | 2017-12-31 | −94.88% | −7.40 pp |
| 2016 | 2016-12-31 | −87.48% | +209.76 pp |
| 2015 | 2015-12-31 | −297.24% | +1268.95 pp |
| 2014 | 2014-12-31 | −1,566.19% | −1076.21 pp |
| 2013 | 2013-12-31 | −489.98% | −65.27 pp |
| 2012 | 2012-12-31 | −424.71% | — |
Volitionrx quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-09-30 | −444.79% | −218.96 pp |
| Q2 2023 | 2023-06-30 | −544.54% | −440.69 pp |
| Q4 2022 | 2022-12-31 | −5,540.15% | −5498.47 pp |
| Q3 2022 | 2022-09-30 | −225.82% | −195.78 pp |
| Q2 2022 | 2022-06-30 | −103.86% | −84.56 pp |
| Q1 2022 | 2022-03-31 | −54.10% | −28.28 pp |
| Q4 2021 | 2021-12-31 | −41.68% | −12.41 pp |
| Q3 2021 | 2021-09-30 | −30.04% | −6.99 pp |
| Q2 2021 | 2021-06-30 | −19.29% | +16.93 pp |
| Q1 2021 | 2021-03-31 | −25.82% | +24.30 pp |
| Q4 2020 | 2020-12-31 | −29.28% | −7.04 pp |
| Q3 2020 | 2020-09-30 | −23.05% | +1.41 pp |
| Q2 2020 | 2020-06-30 | −36.22% | −9.82 pp |
| Q1 2020 | 2020-03-31 | −50.11% | −19.26 pp |
| Q4 2019 | 2019-12-31 | −22.23% | +9.24 pp |
| Q3 2019 | 2019-09-30 | −24.46% | +11.13 pp |
| Q2 2019 | 2019-06-30 | −26.40% | +11.77 pp |
| Q1 2019 | 2019-03-31 | −30.85% | +7.96 pp |
| Q4 2018 | 2018-12-31 | −31.47% | +3.33 pp |
| Q3 2018 | 2018-09-30 | −35.59% | −9.62 pp |
| Q2 2018 | 2018-06-30 | −38.17% | −18.42 pp |
| Q1 2018 | 2018-03-31 | −38.82% | −21.92 pp |
| Q4 2017 | 2017-12-31 | −34.80% | −16.70 pp |
| Q3 2017 | 2017-09-30 | −25.97% | +0.65 pp |
| Q2 2017 | 2017-06-30 | −19.75% | −0.86 pp |
| Q1 2017 | 2017-03-31 | −16.89% | +4.83 pp |
| Q4 2016 | 2016-12-31 | −18.09% | +22.66 pp |
| Q3 2016 | 2016-09-30 | −26.62% | +9.18 pp |
| Q2 2016 | 2016-06-30 | −18.88% | −0.62 pp |
| Q1 2016 | 2016-03-31 | −21.72% | +13.41 pp |
| Q4 2015 | 2015-12-31 | −40.75% | — |
| Q3 2015 | 2015-09-30 | −35.79% | — |
| Q2 2015 | 2015-06-30 | −18.26% | — |
| Q1 2015 | 2015-03-31 | −35.13% | — |
| Q4 2013 | 2013-12-31 | −154.76% | −3.60 pp |
| Q3 2013 | 2013-09-30 | −173.03% | −98.16 pp |
| Q2 2013 | 2013-06-30 | −152.96% | −67.51 pp |
| Q1 2013 | 2013-03-31 | −119.07% | −41.21 pp |
| Q4 2012 | 2012-12-31 | −151.16% | +271.12 pp |
| Q3 2012 | 2012-09-30 | −74.87% | — |
| Q2 2012 | 2012-06-30 | −85.45% | — |
| Q1 2012 | 2012-03-31 | −77.86% | — |
| Q4 2011 | 2011-12-31 | −422.27% | — |
Volitionrx return on equity trends
Over the last five fiscal years, Volitionrx's return on equity decreased from −94.88% to −404.02%, a change of −309.14 percentage points. The latest reported quarter, Q3 2023, shows −444.79%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Volitionrx source filings ↗